Skip to contentE
Enveric Biosciences, Inc.
E
ENVBEnveric Biosciences, Inc. Source filing unavailable
Q4 2015 · —
derived · Computed from the longer spans the company filed.
Revenue$7.58M$7.58Mderivedno prior Q4 2014 on file Net Income-$762.92K-$762.92KderivedN/M vs Q4 2014 EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$3,328,418— The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Enveric Biosciences, Inc. · CIK 890821 · Engraved from SEC EDGAR
Operating Incomederived-$663,937N/M Operating Cash Flowderived$418,855N/M Margins · derivedGross margin43.9%
Operating margin-8.8%
Net margin-10.1%